A GFR of 31 places your kidneys in stage 3b chronic kidney disease (CKD), meaning they are filtering blood at roughly a third of normal capacity. In the standard classification system used worldwide, stage 3b spans GFR values of 30 to 44, so a reading of 31 sits near the lower boundary of this range. This is not kidney failure, but it is far enough along the spectrum that complications begin to surface and active medical management becomes important rather than optional.
What the Number Actually Represents
GFR stands for glomerular filtration rate, and it estimates how many milliliters of blood your kidneys clean per minute, adjusted for body size. A healthy young adult typically filters around 90 to 120 mL/min/1.73 m². At 31, your kidneys are doing roughly a quarter to a third of that work. The number itself is almost always an estimate (eGFR) calculated from a blood test rather than measured directly. Most labs use the creatinine level in your blood to run that calculation, since creatinine is a waste product that accumulates when filtering slows down.
The catch is that creatinine-based estimates can be thrown off by muscle mass, diet, and other factors. A second blood marker called cystatin C often gives a different picture. In routine clinical practice, cystatin C-based estimates tend to run lower than creatinine-based ones, with a majority of paired measurements showing the cystatin C result coming in lower by an average of about 10 percent.
That discordance matters. Research tracking real patient outcomes found that when the two estimates disagree, the cystatin C number tends to predict risk more accurately. Reclassifying someone to a lower eGFR using cystatin C was tied to higher risk of death and cardiovascular events, while reclassifying upward was tied to lower risk.1PubMed Central. Cystatin C versus Creatinine in Determining Risk Based on Kidney Function So if your GFR of 31 was estimated from creatinine alone, a combined creatinine-cystatin C equation, which has been shown to be more accurate than either marker on its own, could shift the number in either direction.2PubMed. Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study If you have not had cystatin C tested, it is worth asking your doctor about, especially if your creatinine result seems out of step with how you feel or with other lab work.
What You Might Feel at Stage 3b
One of the frustrating things about CKD in this range is that many people feel relatively normal, which makes the lab number hard to take seriously. Kidneys have enormous reserve capacity, and symptoms often lag well behind the blood work. But stage 3b is where subtle changes start showing up for a lot of people, even if they are easy to dismiss or attribute to something else.
In qualitative research interviewing patients with CKD stages 2 through 3b, the symptoms that came up most consistently were fatigue, sleep problems, getting up more often at night to urinate, and swelling in the legs, ankles, or feet. Beyond those physical signs, anxiety and a general negative emotional impact were also common themes.3PubMed Central. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief These are not dramatic symptoms, and none of them are specific to kidney disease, which is part of why so many people are caught off guard when they first hear their GFR number.
Quality of life data from a large Chinese cohort comparing stage 3a patients (GFR 45-59) with stage 3b patients (GFR 30-44) found that physical functioning, symptom burden, and the perceived effects of kidney disease were all measurably worse in the 3b group.4PubMed Central. Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE) The differences were real but not enormous, which fits the clinical picture: stage 3b is a transition zone where things are noticeably getting harder, but daily life is still manageable for most people. Interestingly, a Norwegian study found that patients with CKD stages 3b through 4 who were not on dialysis scored similarly to the general population on a broad health-related quality of life survey, though depression and existing health conditions were the strongest predictors of who felt worst.5PubMed. Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4
Cardiovascular Risk and Stage 3b
The biggest immediate health concern for someone with a GFR of 31 is not dialysis; it is heart disease. CKD and cardiovascular disease are deeply intertwined, and at stage 3b the link becomes statistically clear. Data from the Framingham Heart Study found that stage 3b CKD was associated with a roughly 40 percent increase in cardiovascular disease risk over an average of 16 years of follow-up.6The American Journal of Cardiology. Chronic Kidney Disease as a Predictor of Cardiovascular Disease (from the Framingham Heart Study) That is a meaningful increase, though the same study noted that stage 3b CKD on its own was not as dangerous as having already had a cardiovascular event. In other words, it raises your risk but does not by itself put you in the highest risk category.
Low HDL cholesterol appeared to amplify the connection between CKD and cardiovascular disease in that same analysis, which is a useful reminder that managing heart risk at this stage means paying attention to blood pressure, cholesterol, and blood sugar, not just the kidney number.
Complications That Begin at This GFR Range
A GFR of 31 sits right at a physiological threshold where several organ systems start to be affected by the kidneys’ diminished filtering and hormonal functions. Three of the most clinically significant complications at this stage are anemia, bone and mineral disturbances, and metabolic acidosis.
Anemia
Your kidneys produce erythropoietin, the hormone that tells your bone marrow to make red blood cells. As kidney function declines, erythropoietin production does not keep pace with what the body needs. Research measuring GFR directly (not estimated) found that the normal feedback loop between hemoglobin and erythropoietin breaks down right around a GFR of 30. Above that threshold, the body still ramps up erythropoietin when hemoglobin drops, but below it, that response stalls.7PubMed Central. Timing and determinants of erythropoietin deficiency in chronic kidney disease With a GFR of 31, you are right on the edge of that transition. If your hemoglobin or hematocrit levels are trending down, erythropoietin deficiency is a likely contributor and should be on your doctor’s radar.
Bone and Mineral Problems
Healthy kidneys activate vitamin D and help regulate calcium and phosphorus levels. As GFR falls, phosphorus clearance drops, active vitamin D production slows, and parathyroid hormone levels rise in response. This cascade, collectively called CKD-mineral bone disease, leads to weakened bones, abnormal bone turnover, and in some cases calcification of blood vessels and soft tissues.8PubMed. Mineral bone disorders in chronic kidney disease At a GFR of 31, these disturbances are usually present to some degree. Your doctor will probably be checking your calcium, phosphorus, parathyroid hormone, and vitamin D levels and may start you on phosphate binders or active vitamin D supplements if the numbers are off.
Metabolic Acidosis
Kidneys are responsible for clearing the acid your body produces every day. As nephron mass shrinks, the remaining nephrons work harder per unit but eventually cannot keep up. The resulting acid buildup, diagnosed when serum bicarbonate drops below about 22 mEq/L, speeds up further kidney decline and contributes to muscle wasting and bone loss.9PubMed Central. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment What complicates this is that acid can accumulate even before bicarbonate levels visibly drop on a standard blood test, a state sometimes called subclinical acidosis.10Kidney Medicine. Metabolic Acidosis and Chronic Kidney Disease: Management and Update If your bicarbonate is borderline or low, your doctor may recommend oral bicarbonate supplementation or dietary changes to reduce your daily acid load.
Why Albuminuria Matters as Much as GFR
If your doctor has only been tracking your GFR, you are getting an incomplete picture. The amount of protein, specifically albumin, leaking into your urine is an independent predictor of how fast your kidneys will decline and whether you will eventually need dialysis. A large meta-analysis found that a fourfold increase in the urine albumin-to-creatinine ratio (ACR) was associated with roughly triple the risk of progressing to end-stage kidney disease, while a fourfold decrease cut that risk by about two-thirds. These associations held regardless of whether someone had diabetes or hypertension and remained significant even after accounting for changes in eGFR over the same period.11PubMed Central. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
In practical terms, two people can both have a GFR of 31 and face very different futures. One with minimal protein in the urine may stay stable for years. Another with heavy proteinuria may progress to dialysis within a few years. This is why international guidelines use a grid of GFR and albuminuria together to stage CKD and determine who needs the most aggressive treatment. If you have not had a urine albumin test recently, ask for one.
Medications That Can Slow Progression
A GFR of 31 is not just a number to watch; it is a signal to intervene. The mainstays of kidney-protective therapy have evolved considerably in recent years. Blood pressure control remains foundational, and ACE inhibitors or ARBs (the common blood pressure drugs that act on the renin-angiotensin system) have been the standard kidney-protective medications for decades.12Clinical Kidney Journal. The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)
The bigger recent development is SGLT2 inhibitors, a class of drugs originally developed for diabetes that turned out to have powerful kidney-protective effects independent of blood sugar control. These medications reduce pressure inside the kidney’s filtering units and have slowed CKD progression in multiple large trials, including one stopped early because the benefits were so clear.13PubMed Central. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations In a real-world study of patients with CKD stages 3b through 4 who were started on an SGLT2 inhibitor, the median annual decline in eGFR went from losing nearly 4 mL/min per year before treatment to essentially flat afterward, and urinary protein excretion dropped significantly as well.14PubMed Central. Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center
If you have a GFR of 31 and are not already on an SGLT2 inhibitor (common brand names include dapagliflozin and empagliflozin), it is worth discussing with your doctor. These drugs do carry some side effects, including urinary tract infections and a risk of dehydration, and your doctor will want to make sure your potassium and kidney function are monitored when starting them. But for many people at this stage, the benefit in slowing progression is substantial.
When You Should See a Nephrologist
International guidelines from KDIGO recommend referral to a nephrologist when eGFR falls persistently below 30 mL/min/1.73 m².15Clinical Kidney Journal. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease At 31, you are hovering just above that threshold. Whether you are referred now or soon, the case for specialist involvement is strong at this stage. A nephrologist can coordinate the increasingly complex medication picture, monitor for the complications discussed above, and begin long-term planning in case kidney function continues to decline. Referral is also recommended regardless of GFR when heavy albuminuria (urine ACR above 300 mg/g), rapidly worsening kidney function, persistent potassium abnormalities, or CKD-related anemia are present.
One limitation of the standard referral guidelines is that they use the same GFR thresholds for everyone, regardless of age. That matters because a 40-year-old with a GFR of 31 is in a very different clinical situation from an 80-year-old with the same number, yet the guidelines treat them the same. Risk-based referral models that account for age, albuminuria, and rate of decline are gaining support as a way to allocate nephrology resources more effectively.
Age, GFR, and the Possibility of Overdiagnosis
Kidney function naturally declines with age. This does not mean a GFR of 31 is “normal for your age” in any reassuring sense, but age does complicate interpretation. Research on aging and kidney function has shown that the commonly used estimation equations tend to underestimate true GFR in older adults, with one widely used formula underestimating by as much as 25 percent in elderly populations.16PubMed. Aging and chronic kidney disease That bias can lead to healthy older people being classified as having CKD when their kidneys are actually functioning adequately for their age and body size.
For a younger person, a GFR of 31 is unambiguously abnormal and warrants urgent attention. For someone in their 80s with stable kidney function, no proteinuria, and no complications, the clinical meaning is less dire, though the number still deserves monitoring. The key factor is not the snapshot but the trend. A stable GFR of 31 that has not changed in two years tells a different story than one that was 50 a year ago and is still dropping.
Can GFR Recover
Chronic kidney disease, by definition, reflects lasting structural damage, and lost nephrons do not regenerate. But that does not mean a GFR reading can never improve. Some of the factors that push GFR down are reversible: dehydration, a medication side effect, an acute illness, or uncontrolled blood pressure. If any of those are corrected, the number can bounce back somewhat.
Acute kidney injury (AKI), a sudden drop in kidney function triggered by severe illness, surgery, or certain drugs, is a distinct concern for people who already have CKD. A nationwide population-based study found that among individuals with a baseline eGFR below 60, an episode of AKI led to a median drop of about 2 mL/min in GFR, though individual outcomes varied widely, with some people losing much more and others partially recovering.17PubMed Central. Kidney function before and after acute kidney injury: a nationwide population-based cohort study For someone already at 31, even a small additional hit from AKI could push them into stage 4 (GFR below 30), making prevention of acute episodes through careful hydration and medication management especially important.
Genetic Factors That Affect How Fast Things Progress
Not everyone with a GFR of 31 got there the same way, and not everyone will progress at the same speed. Beyond the well-known drivers like diabetes, hypertension, and proteinuria, genetics play a real role. The most striking example involves variants in a gene called APOL1, which are carried predominantly by people of recent West African ancestry. Carrying two copies of the risk variants raises the odds of hypertension-associated kidney failure roughly seven- to tenfold and is tied to faster CKD progression regardless of the underlying cause.18PubMed Central. APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene
APOL1 testing is not yet a standard part of CKD workups everywhere, but awareness is growing. If you are of African descent and your kidney disease has been progressing faster than expected or does not have a clear cause, APOL1 testing may help clarify your risk and guide how aggressively your doctors approach treatment. Research into therapies that specifically target APOL1-mediated kidney injury is ongoing, though nothing specifically designed for it has reached routine clinical use yet.
Practical Steps If Your GFR Is 31
Knowing the science matters, but so does knowing what to do next. If you have just received a GFR result of 31, there are a few concrete actions that make a real difference:
- Get a urine albumin test: If you have not had one recently, this is the single most important additional piece of information for predicting your trajectory.
- Review your medications: NSAIDs (ibuprofen, naproxen) are particularly hard on kidneys at this stage, and many medications need dose adjustments below a GFR of 30-40. Ask your pharmacist or doctor to review everything you take.
- Ask about SGLT2 inhibitors: If you are not already on one and your kidney function and potassium levels allow it, the evidence for benefit at this stage is strong.
- Monitor blood pressure closely: Keeping blood pressure under control is the single most established way to slow kidney decline. The target most guidelines recommend for CKD patients is below 120 systolic when tolerated.
- Watch your diet: At a GFR of 31, you may need to limit sodium, potassium, phosphorus, and protein intake depending on your blood work. A referral to a renal dietitian is reasonable.
- Stay hydrated but do not overdo it: Dehydration is one of the most common triggers for acute drops in kidney function. Drink enough to keep your urine a pale yellow, but forced high-volume water intake does not help and can be harmful.
- Track the trend: A single GFR reading is a snapshot. What matters most is whether the number is stable, declining slowly, or dropping fast. Ask your doctor to compare your last several results and calculate your rate of decline.
A GFR of 31 does not mean dialysis is around the corner. Many people live for years or even decades at this level, especially with good management. But this is the stage where passively monitoring is no longer enough and active intervention starts paying real dividends.